Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ORCHID CELLMARK INC | 3,962,179 | reported | 12 Dec 2008 | tx 1+915,110 |
| Cardiff Oncology, Inc. | 2,850,587 | reported | 27 Feb 2015 | tx 3+263,286 |
| TRIMERIS INC | 2,510,081 | reported | 21 Aug 2007 | tx 1+10,081 |
| Avanti Acquisition Corp. | 1,000,000 | reported | 01 Oct 2020 | tx 1+1,000,000 |
| Guardant Health, Inc. | 7,920 | reported | 21 Apr 2026 | tx 18+47,993−4,751 |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | 7,242 | reported | 28 May 2026 | tx 32+974,408−1,237,715 |
| RESPONSE GENETICS INC | 0 | reported | 18 Nov 2015 | tx 2−4,635,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 7,242 | 0.00 USD | deriv |
| 21 Apr 2026 | EXERCISE | Guardant Health, Inc. | 264 | 0.00 USD | |
| 21 Apr 2026 | EXERCISE | Guardant Health, Inc. | 264 | 0.00 USD | deriv |
| 21 Mar 2026 | EXERCISE | Guardant Health, Inc. | 264 | 0.00 USD | |
| 21 Mar 2026 | EXERCISE | Guardant Health, Inc. | 264 | 0.00 USD | deriv |
| 21 Feb 2026 | EXERCISE | Guardant Health, Inc. | 264 | 0.00 USD | |
| 21 Feb 2026 | EXERCISE | Guardant Health, Inc. | 264 | 0.00 USD | deriv |
| 21 Jan 2026 | EXERCISE | Guardant Health, Inc. | 264 | 0.00 USD | |
| 21 Jan 2026 | EXERCISE | Guardant Health, Inc. | 264 | 0.00 USD | deriv |
| 21 Dec 2025 | EXERCISE | Guardant Health, Inc. | 264 | 0.00 USD | |
| 21 Dec 2025 | EXERCISE | Guardant Health, Inc. | 264 | 0.00 USD | deriv |
| 16 Dec 2025 | SALE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 77,400 | 30.24 USD | |
| 26 Nov 2025 | SALE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 50,000 | 26.03 USD | |
| 21 Nov 2025 | EXERCISE | Guardant Health, Inc. | 264 | 0.00 USD | |
| 21 Nov 2025 | EXERCISE | Guardant Health, Inc. | 264 | 0.00 USD | deriv |
| 06 Nov 2025 | SALE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 200,000 | 24.11 USD | |
| 21 Oct 2025 | EXERCISE | Guardant Health, Inc. | 3,167 | 0.00 USD | |
| 21 Oct 2025 | EXERCISE | Guardant Health, Inc. | 3,167 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | Guardant Health, Inc. | 6,833 | 0.00 USD | deriv |
| 18 Jun 2025 | GRANT_AWARD | Guardant Health, Inc. | 4,203 | 0.00 USD | deriv |
| 06 Jun 2025 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 9,632 | — | |
| 06 Jun 2025 | EXERCISE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 9,632 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | TEVA PHARMACEUTICAL INDUSTRIES LTD | 14,492 | 0.00 USD | deriv |
| 20 Dec 2024 | SALE | TEVA PHARMACEUTICAL INDUSTRIES LTD | 286,000 | 22.01 USD | |
| 08 Nov 2024 | GRANT_AWARD | Guardant Health, Inc. | 12,671 | 0.00 USD | deriv |
4 purchases reported after at least 12 months of silence — most recent on 01 Oct 2020.